2024-01-22 01:45:50
The ARS Mayotte is clear when it warns: “Be careful, we are still in the epidemic phase concerning bronchiolitis, the virus is still circulating! » To support this observation, Dr. Jean alerts us to the fact that “ 5 babies were admitted to intensive care last week ».
For Dr. Jean, “bronchiolitis is a serious illness”, for which monitoring and home care are essential, to avoid the need for hospitalization (archives)
Representatives of the health authority are deploying their efforts with their partners, such as Maternal and Child Protection (PMI) and the liberals, to improve the prevention et caring for children at home“to limit hospitalization as much as possible”.
Dr. Jean recognizes this: “Generally, all parents know regarding bronchiolitis but home care is still too late (…) previously, 1 in 2 children who arrived at the emergency room with symptoms of bronchiolitis were hospitalized. » Since then, measures have been deployed to limit the hospital impact and improve monitoring and care of children at home.
Indeed, Dr. Jean explains that too often “ parents realize belatedly the severity of their child’s symptoms”but fortunately, PMI staff are “well prepared to show parents how to manage their child’s illnesshis provide home care et monitor your symptoms at home“, as attested by Mathilde Lozano, coordinator of midwives in PMI.
“BRONCHIOLITIS IS A SERIOUS DISEASE”
Midwife from the Kawéni PMI, explaining the actions to take to help a child sick with bronchiolitis breathe better, Friday January 19, 2024 (@Mathildehangard)
Thus, an important “communication system must be continued with families to improve the care of children suffering from bronchiolitis at home”, maintains Dr. Jean. As the infectious disease specialist points out, “bronchiolitis is a serious illness »,. Indeed, as it affects many children each year, our minds may tend to minimize this illness. However, as Dr. Jean explains, “bronchiolitis is serious, particularly because babies are not able to breathe through their mouthso when their nose is blocked, they cannot breathe (…) a child who has bronchiolitis can’t even eat because he can’t breathe.
Mathilde Lozano, coordinator of midwives in PMI, during the ARS press conference Friday January 19, 2024, on the subject of bronchiolitis, conjunctivitis and typhoid fever (@Mathildehangard)
Bastien Morvan, the chief of staff of the ARS, affirmed that the PMIs have stocks of medicines and physiological serums to deal with this epidemic, as well as nurses, midwives and physiotherapists. These kits can be left with families to continue care at home.
“The objective of this home monitoring and PMI consultations is precisely to fight once morest delays in support, to prevent sick children from arriving at the CHM in very degraded conditions. »insisted Bastien Morvan.
IN MAYOTTE, More than 1,300 children were protected by Beyfortus
The representatives of the ARS also recalled the “positive support” that the treatment had experienced. Nirsevimab (Beyfortus) among the Mahorese population during its deployment. As a reminder, this treatment is a monoclonal antibody for children who would be exposed, for the first time, to the circulation of the bronchiolitis virus. It is not a vaccine but antibodieswhose protection would be active for almost six months, preventing the virus causing bronchiolitis from infecting the baby following the injection.
Nirsevimab treatment (Beyfortus) is a recent, preventive treatment to limit the risks of bronchiolitis in infants (illustration/DR)
According to ARS figures, more than 1,300 children benefited from this treatment in Mayotte. On the subject of the Beyfortus treatment, Maxime Jean welcomed the major work carried out by the ARS in connection with its Parisian supervision: “In mainland France, 70% of the doses of Beyfortus were granted in relation to the total number of births ( …) In Mayotte, the ARS demanded and obtained from the General Directorate of Health (DGS) that it grant 100% of doses of Beyfortus treatment compared to the number of births in Mayotte ».
In the corridors of pediatric emergencies and pediatric intensive care, a positive impact of Beyfortus on bronchiolitis might be observed. The emergency doctors and pediatricians at CHM confided to Dr. Jean a simple perception, which might be encouraging. In fact, the latter might already observe a reduction in the duration of hospitalizations of children who would have been immunized thanks to the Beyfortus treatment.
These observations, if not scientific, might be the first indicators, hopefully encouraging, for the management of this bronchiolitis epidemic which is still raging and which we will continue to follow!
Mathilde Hangard
1705888938
#bronchiolitis #epidemic #ongoing
